Physician

Erin Trahan Pratt, M.D.

According to 2025 Medicare claims, Erin Pratt, M.D. (NPI: 1124297627) practices allergy/immunology in the Lafayette, LA market, with the plurality of this provider's patient population coming from Lafayette, LA. This provider's primary affiliated billing organization is ACADIANA ALLERGY, ASTHMA AND IMMUNOLOGY CENTER, LLC (NPI: 1508227604; TIN: 811073954) and primary practice location at 70508-8511. Pratt is affiliated with the Ochsner Senior Care Network, LLC (ACO ID: A5662), participating under the MSSP model.

Pratt's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 235 traditional Medicare patients, billed 13,161 HCPCS/CPT codes, and received $1,448,152 in Medicare payments. The top billing code was 90732 (Pneumococcal vaccine, 23-valent). Part D data shows 1,027 prescription claims across 179 beneficiaries totaling $595,080 in drug costs, led by Dupixent Syringe (Dupilumab). DME data shows 1,643 claims. Open Payments data shows 127 records totaling $4,055. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $2,149 to $1,448,152. Similarly, Part D prescription costs have risen steadily, from $6,024 to $595,080. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $759 to $30,653.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	13	139	$2,149
2016	37	748	$10,573
2017	57	941	$15,599
2018	89	2,307	$39,239
2019	117	2,730	$55,081
2020	154	3,758	$92,547
2021	178	5,118	$119,960
2022	186	3,505	$82,089
2023	189	4,617	$314,666
2024	235	13,161	$1,448,152

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	30	$6,024
2016	14	89	$45,991
2017	32	173	$95,123
2018	70	433	$365,650
2019	86	505	$576,609
2020	84	571	$468,213
2021	107	592	$340,549
2022	127	766	$518,065
2023	147	769	$466,481
2024	179	1,027	$595,080

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	21	$39,500
2017	N/R	79	$116,663
2018	N/R	138	$170,044
2019	N/R	219	$215,429
2020	N/R	435	$627,282
2021	32	754	$1,187,140
2022	90	1,102	$1,893,245
2023	98	1,276	$2,500,590
2024	141	1,643	$3,525,464

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
90732	Pneumococcal vaccine, 23-valent	24	24	$131
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	70	70	$97
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	180	236	$84
G0009	Administration of pneumococcal vaccine	23	23	$24
95004	Test for allergy using allergenic extract	33	1,656	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Dupixent Syringe	Dupilumab	22	602	$132,462
Xolair	Omalizumab	43	1,204	$127,484
Hizentra	Immun Glob G(Igg)/Pro/Iga 0-50	21	546	$76,569
Tezspire	Tezepelumab-Ekko	19	532	$75,613
Dupixent Pen	Dupilumab	19	532	$71,011

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1559	Injection, immune globulin (hizentra), 100 mg	N	19	189	$851,082
J1555	Injection, immune globulin (cuvitru), 100 mg	N	13	132	$796,850
J1554	Injection, immune globulin (asceniv), 500 mg	N	N/R	14	$450,755
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	N	11	79	$267,471
J1459	Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg	N	N/R	76	$229,623

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	127	$4,055	GENZYME CORPORATION
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Erin Trahan Pratt, M.D.?

Tedicare shows public-source Medicare data for Erin Trahan Pratt, M.D. (NPI 1124297627), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Erin Trahan Pratt, M.D. have ACO affiliation data?

Erin Trahan Pratt, M.D. is shown with ACO affiliation data for Ochsner Senior Care Network, LLC (MSSP, ACO ID A5662).

What billing organization is linked to Erin Trahan Pratt, M.D.?

Erin Trahan Pratt, M.D. is linked to ACADIANA ALLERGY, ASTHMA AND IMMUNOLOGY CENTER, LLC (billing NPI 1508227604) in the available physician profile data.

Does Erin Trahan Pratt, M.D. have Open Payments data?

Erin Trahan Pratt, M.D. has 127 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.